Scleroderma
Scleroderma is an immune-related condition. The provided data does not include details about its symptoms, causes, or how it affects the body, so a fuller description cannot be given here without adding unsupported information.
Scleroderma is an immune-related condition. This page provides a simple overview for educational reference and related wellness research.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
2 options:2 not enough evidence
Mindfulness MeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A quasi-experimental study involving 32 people with SSc found better anger control and expression than with a waitlist, while most other outcomes did not change.
Open the Mindfulness Meditation pageCupping TherapypracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2021 review described benefit for limited scleroderma in one case series, but also a case report of deep ulcerations after cupping in circumscribed scleroderma.
Open the Cupping Therapy page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition2 listedThe best we have, but the evidence is still weak
- →PracticesMindfulness MeditationCertaintyLowSourceClinical
A quasi-experimental study involving 32 people with SSc found better anger control and expression than with a waitlist, while most other outcomes did not change.
Who was studied
- People with a condition
- Scleroderma
Open Mindfulness MeditationStudy result
Significant anger control and expression improvements vs waitlist in SSc patients; most other outcomes did not change, so the indication is limited.
- →PracticesCupping TherapyCertaintyLowSourceReview
A 2021 review described benefit for limited scleroderma in one case series, but also a case report of deep ulcerations after cupping in circumscribed scleroderma.
Who was studied
- People with a condition
- Ankylosing Spondylitis
- Gout
- Osteoarthritis
- Psoriasis
- Rheumatoid Arthritis
- Scleroderma
- +1 more
Open Cupping TherapyStudy result
One case series found benefit for limited scleroderma, but one case report described deep ulcerations after cupping in circumscribed scleroderma.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Scleroderma worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Scleroderma is an immune-related condition. The provided data does not include details about its symptoms, causes, or how it affects the body, so a fuller description cannot be given here without adding unsupported information.
If you are looking into this condition, it is best understood through a clinician who can explain its specific presentation and management in context.
Evidence-backed options
No evidence-backed options are listed here for Scleroderma in the provided data. This means the current evidence set does not identify any specific supplement or wellness option that can be described for this condition on this page.
If you are reviewing treatment or support options for Scleroderma, the most useful next step is to discuss the condition with a clinician who can interpret the full medical context and help determine what is appropriate. This section will remain limited to options that are specifically supported in the source data.
What to avoid
For scleroderma, the main items flagged as avoid are 5-HTP and Betaine HCl. These entries come from pharmacology reference data, so they reflect interaction-style caution rather than a full clinical recommendation by themselves.
If either of these is being considered, a clinician familiar with the condition can help judge whether it is appropriate in the context of the person’s overall treatment plan and symptoms. In a condition like scleroderma, it is especially important to review all supplements and digestive products with a healthcare professional before use.